| alcohol – ECG | |
| Nicotine-Cotinine | |
| morphine- codeine | |
| oxycodone | |
| demerol | |
| methadone-eddp | |
| fentanyl | |
| carfentanil | |
| nitazines | |
| other designer opioids | |
| MDMA | |
| amphetamine | |
| benzodiazepines | |
| PCP | |
| psyilocybin | |
| ketamine | |
| Barbituates | |
| Glue | |
| Paint | |
| THC |
Top 10 Vendors of Drugs of Abuse Screening Tests
The global market for drugs of abuse screening is highly competitive, with several major companies leading in the development and distribution of rapid tests, laboratory-based systems, and integrated screening solutions. Here are the top 10 vendors widely recognized for their market presence and technological leadership:
| Rank | Company Name | Notable Offerings/Description |
| 1 | Abbott Laboratories | Rapid point-of-care tests; global reach |
| 2 | Quest Diagnostics | Comprehensive laboratory testing services |
| 3 | LabCorp (Laboratory Corporation of America) | Extensive lab-based drug testing |
| 4 | Thermo Fisher Scientific | Automated systems, reagents, and kits |
| 5 | Siemens Healthineers | Wide range of clinical diagnostics solutions |
| 6 | F. Hoffmann-La Roche (Roche Diagnostics) | Immunoassay analyzers, reagents |
| 7 | Drägerwerk AG & Co. KGaA | Evidential and workplace breathalyzers |
| 8 | OraSure Technologies | Oral fluid drug testing products |
| 9 | Premier Biotech | Innovative rapid test devices |
| 10 | Omega Laboratories | Specialized lab hair and urine testing |
| 11 | San Diego Reference Laboratories | lab based LC-MS after prelim screening |
These companies provide a mix of laboratory-based services, on-site testing kits, and point-of-care solutions for various professional, clinical, law enforcement, and workplace settings. Many offer products approved or cleared by regulatory agencies such as the FDA, and have a global distribution network[1][2][3].
Other strong industry participants include Bio-Rad Laboratories, Randox, Psychemedics, MP Biomedicals, and Intoximeters, Smartox -Inotelligent Biosolutions, among others, each catering to specific segments or test formats in the drugs of abuse screening market[1][2][4].
The landscape remains dynamic with ongoing innovation in immunoassay techniques, chromatography, and integration of digital result management systems.
⁂